Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
International Archives of Allergy and Immunology
|
September 25, 2025
Prevalence of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA Registry
Martin Desrosiers, Tanya M Laidlaw, Andrew A White, et al.
ERJ Open Research
|
November 29, 2023
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
Christian Domingo, Klaus F Rabe, David Price, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 12, 2026
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)
Simon Couillard, Nayia Petousi, Sanjay Ramakrishnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 29, 2024
Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE
Daniel J Jackson, Eckard Hamelmann, Graham Roberts, et al.
Journal of Asthma and Allergy
|
February 13, 2024
Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
Theresa W Guilbert, Kevin R Murphy, Eckard Hamelmann, et al.
American Journal of Rhinology & Allergy
|
September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps
Zachary M Soler, Zara M Patel, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 18, 2026
Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level
Wanda Phipatanakul, Nikolaos G Papadopoulos, Vivian Hernandez-Trujillo, et al.
The Journal of Allergy and Clinical Immunology
|
November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthma
Ian D Pavord, Njira L Lugogo, Mario Castro, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthma
William W Busse, Monica Kraft, Christian Domingo, et al.
Advances in Therapy
|
December 9, 2024
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
Njira L Lugogo, Xavier Soler, Yasuhiro Gon, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
International Archives of Allergy and Immunology
|
September 25, 2025
Prevalence of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA Registry
Martin Desrosiers, Tanya M Laidlaw, Andrew A White, et al.
ERJ Open Research
|
November 29, 2023
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
Christian Domingo, Klaus F Rabe, David Price, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 12, 2026
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)
Simon Couillard, Nayia Petousi, Sanjay Ramakrishnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 29, 2024
Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE
Daniel J Jackson, Eckard Hamelmann, Graham Roberts, et al.
Journal of Asthma and Allergy
|
February 13, 2024
Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
Theresa W Guilbert, Kevin R Murphy, Eckard Hamelmann, et al.
American Journal of Rhinology & Allergy
|
September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps
Zachary M Soler, Zara M Patel, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 18, 2026
Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level
Wanda Phipatanakul, Nikolaos G Papadopoulos, Vivian Hernandez-Trujillo, et al.
The Journal of Allergy and Clinical Immunology
|
November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthma
Ian D Pavord, Njira L Lugogo, Mario Castro, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthma
William W Busse, Monica Kraft, Christian Domingo, et al.
Advances in Therapy
|
December 9, 2024
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
Njira L Lugogo, Xavier Soler, Yasuhiro Gon, et al.
Page
of 4